Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration today issued a final guidance to help co-developers of antimicrobial drugs and tests coordinate development of the therapy and test and ensure that these products become available on the market around the same time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.